Bridget Hoyt

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.

Among patients with solid tumors, baseline emotional functioning was moderate, with lower functioning for female and younger patients.

For patients with HRRm prostate cancer receiving Akeega with prednisone, quality of life remained at baseline.

An LED-based intraoral device was safe and reduced severe oral mucositis and throat pain in patients receiving radiotherapy for head and neck cancers.

A structured nurse-led clinic can help patients with myeloproliferative neoplasms receive timely support, as well as bridge gaps in symptom reporting.

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.